» Articles » PMID: 20585902

Copy-number Increase of AURKA in Gastric Cancers in a Chinese Population: a Correlation with Tumor Progression

Overview
Journal Med Oncol
Publisher Springer
Specialty Oncology
Date 2010 Jun 30
PMID 20585902
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The centrosome-associated kinase aurora A (AURKA) has been shown to be involved in genetic instability and to be over-expressed in several human carcinomas including gastric cancers (GCs). The chromosome locus of AURKA, 20q13, is frequently amplified in GCs, and the functional impact of such regions needs to be extensively investigated in large amount of clinical samples. Case-matched tissues of gastric carcinomas and adjacent normal epithelium (n=141) were included in this study. Quantitative PCR was carried out to examine the copy number and mRNA expression of AURKA in GCs. Our results showed copy-number gains of AUKRA were detected in a relative high percentage of GC samples (30.5%, 43 out of 141). There was a positive correlation between copy-number increase of AURKA and tumor progression. And copy-number gains of AURKA also showed a positive correlation with mRNA over-expression in GCs. However, expression level of AURKA mRNA was also enhanced in the group of GC samples with unaltered copy numbers. These findings indicated that sporadic gastric cancers exhibit different mechanisms of AURKA regulation and that this may impact the efficacy of aurora-targeted therapies.

Citing Articles

Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.

Nemtsova M, Kuznetsova E, Bure I Int J Mol Sci. 2023; 24(23).

PMID: 38069284 PMC: 10707305. DOI: 10.3390/ijms242316961.


Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.

Wang L, Arras J, Katsha A, Hamdan S, Belkhiri A, Ecsedy J Mol Oncol. 2017; 11(8):981-995.

PMID: 28417568 PMC: 5537695. DOI: 10.1002/1878-0261.12066.


Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.

Zhou Y, Hao Y, Li Y, Li R, Wu R, Wang S BMC Cancer. 2017; 17(1):230.

PMID: 28356144 PMC: 5372318. DOI: 10.1186/s12885-017-3201-0.


Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases.

Lee K, Jin H, Ye S, Park B, Kim S Oncotarget. 2016; 7(45):73473-73485.

PMID: 27636990 PMC: 5341992. DOI: 10.18632/oncotarget.11969.


Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.

Liang L, Fang J, Xu J Oncogene. 2015; 35(12):1475-82.

PMID: 26073079 DOI: 10.1038/onc.2015.209.


References
1.
Vauhkonen H, Vauhkonen M, Sipponen P, Knuutila S . Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Cytogenet Genome Res. 2007; 119(1-2):39-45. DOI: 10.1159/000109617. View

2.
Dar A, Zaika A, Piazuelo M, Correa P, Koyama T, Belkhiri A . Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer. 2008; 112(8):1688-98. PMC: 4030394. DOI: 10.1002/cncr.23371. View

3.
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K . Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer. 2001; 84(6):824-31. PMC: 2363814. DOI: 10.1054/bjoc.2000.1684. View

4.
Jeng Y, Peng S, Lin C, Hsu H . Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res. 2004; 10(6):2065-71. DOI: 10.1158/1078-0432.ccr-1057-03. View

5.
Kyrlagkitsis I, Karamanolis D . Genes and gastric cancer. Hepatogastroenterology. 2004; 51(55):320-7. View